Mapping the landscape of artificial intelligence applications against COVID-19

J Bullock, A Luccioni, KH Pham, CSN Lam… - Journal of Artificial …, 2020 - jair.org
COVID-19, the disease caused by the SARS-CoV-2 virus, has been declared a pandemic by
the World Health Organization, which has reported over 18 million confirmed cases as of …

A review of modern technologies for tackling COVID-19 pandemic

A Kumar, PK Gupta, A Srivastava - Diabetes & Metabolic Syndrome …, 2020 - Elsevier
Objective Science and technology sector constituting of data science, machine learning and
artificial intelligence are contributing towards COVID-19. The aim of the present study is to …

Artificial intelligence and machine learning to fight COVID-19

A Alimadadi, S Aryal, I Manandhar… - Physiological …, 2020 - journals.physiology.org
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2)(13), has become an unprecedented public health crisis …

[PDF][PDF] Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study

S Khaerunnisa, H Kurniawan, R Awaluddin, S Suhartati… - Preprints, 2020 - lavierebelle.org
COVID-19, a new strain of coronavirus (CoV), was identified in Wuhan, China, in 2019. No
specific therapies are available and investigations regarding COVID-19 treatment are …

[HTML][HTML] Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease

C Shivanika, D Kumar, V Ragunathan… - … structure & dynamics, 2020 - ncbi.nlm.nih.gov
The study aims to evaluate the potency of two hundred natural antiviral phytocompounds
against the active site of the Severe Acquired Respiratory Syndrome-Coronavirus− 2 (SARS …

Artificial intelligence for COVID-19 drug discovery and vaccine development

A Keshavarzi Arshadi, J Webb, M Salem… - Frontiers in Artificial …, 2020 - frontiersin.org
SARS-COV-2 has roused the scientific community with a call to action to combat the growing
pandemic. At the time of this writing, there are as yet no novel antiviral agents or approved …

Peptide-like and small-molecule inhibitors against Covid-19

S Pant, M Singh, V Ravichandiran… - Journal of …, 2021 - Taylor & Francis
Coronavirus disease strain (SARS-CoV-2) was discovered in 2019, and it is spreading very
fast around the world causing the disease Covid-19. Currently, more than 1.6 million …

Artificial intelligence (AI) and big data for coronavirus (COVID-19) pandemic: a survey on the state-of-the-arts

QV Pham, DC Nguyen, T Huynh-The, WJ Hwang… - IEEE …, 2020 - ieeexplore.ieee.org
The very first infected novel coronavirus case (COVID-19) was found in Hubei, China in Dec.
2019. The COVID-19 pandemic has spread over 214 countries and areas in the world, and …

COVID-19 open source data sets: a comprehensive survey

J Shuja, E Alanazi, W Alasmary, A Alashaikh - Applied Intelligence, 2021 - Springer
In December 2019, a novel virus named COVID-19 emerged in the city of Wuhan, China. In
early 2020, the COVID-19 virus spread in all continents of the world except Antarctica …

Leveraging data science to combat COVID-19: A comprehensive review

S Latif, M Usman, S Manzoor, W Iqbal… - IEEE Transactions …, 2020 - ieeexplore.ieee.org
COVID-19, an infectious disease caused by the SARS-CoV-2 virus, was declared a
pandemic by the World Health Organisation (WHO) in March 2020. By mid-August 2020 …